{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T16:05:15Z","timestamp":1784217915397,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,10,27]],"date-time":"2018-10-27T00:00:00Z","timestamp":1540598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00277-018-3528-x","type":"journal-article","created":{"date-parts":[[2018,10,27]],"date-time":"2018-10-27T11:41:35Z","timestamp":1540640495000},"page":"369-379","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Real-life data on safety and efficacy of autologous stem cell transplantation in elderly patients with multiple myeloma"],"prefix":"10.1007","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2452-8032","authenticated-orcid":false,"given":"Carolina","family":"Marini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00e2nia","family":"Maia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Bergantim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Pires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Eduardo","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Trigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,27]]},"reference":[{"issue":"3","key":"3528_CR1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.clml.2016.12.002","volume":"17","author":"K Bergin","year":"2017","unstructured":"Bergin K, McQuilten Z, Moore E, Wood E, Spencer A (2017) Myeloma in the real world: what is really happening? Clin Lymphoma Myeloma Leuk 17(3):133\u2013144","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"3","key":"3528_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.4065\/mcp.2009.0426","volume":"85","author":"I Turesson","year":"2010","unstructured":"Turesson I, Velez R, Kristinsson SY, Landgren O (2010) Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the clinic. Mayo Clin Proc 85(3):225\u2013230","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"3528_CR3","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1182\/blood-2007-08-104984","volume":"111","author":"H Brenner","year":"2008","unstructured":"Brenner H, Gondos A, Pulte D (2008) Recent major improvement in long-term survival of younger patients with multiple myeloma. Blood 111(5):2521\u20132526","journal-title":"Blood"},{"issue":"15","key":"3528_CR4","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1200\/JCO.2006.09.0100","volume":"25","author":"SY Kristinsson","year":"2007","unstructured":"Kristinsson SY, Landgren O, Dickman PW, Derolf AR, Bj\u00f6rkholm M (2007) Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003. J Clin Oncol 25(15):1993\u20131999","journal-title":"J Clin Oncol"},{"issue":"2","key":"3528_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1056\/NEJM199607113350204","volume":"335","author":"M Attal","year":"1996","unstructured":"Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF, Casassus P, Maisonneuve H, Facon T, Ifrah N, Payen C, Bataille R (1996) A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Fran\u00e7ais du My\u00e9lome. N Engl J Med 335(2):91\u201397","journal-title":"N Engl J Med"},{"issue":"1","key":"3528_CR6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1182\/blood.V93.1.55","volume":"93","author":"B Barlogie","year":"1999","unstructured":"Barlogie B, Jagannath S, Desikan KR, Mattox S, Vesole D, Siegel D, Tricot G, Munshi N, Fassas A, Singhal S, Mehta J, Anaissie E, Dhodapkar D, Naucke S, Cromer J, Sawyer J, Epstein J, Spoon D, Ayers D, Cheson B, Crowley J (1999) Total therapy with the tandem transplant for newly diagnosed multiple myeloma. Blood 93(1):55\u201365","journal-title":"Blood"},{"issue":"199","key":"3528_CR7","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1056\/NEJMoa022340","volume":"348","author":"JA Child","year":"2003","unstructured":"Child JA, Morgan GJ, Davies FE, Owen RG, Bell SE, Hawkins K, Brown J, Drayson MT, Selby PJ, Medical Research Council Adult Leukaemia Working Party (2003) High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 348(199):1875\u20131883","journal-title":"N Engl J Med"},{"issue":"1","key":"3528_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/annonc\/mdt509","volume":"25","author":"M Merz","year":"2014","unstructured":"Merz M, Neben K, Raab MS, Sauer S, Egerer G, Hundemer M, Hose D, Kunz C, Hei\u00df C, Ho AD, Goldschmidt H, Hillengass J (2014) Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents. Ann Oncol 25(1):189\u2013195","journal-title":"Ann Oncol"},{"issue":"2","key":"3528_CR9","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00277-016-2882-9","volume":"96","author":"YC Cohen","year":"2017","unstructured":"Cohen YC, Zuckerman T, Yeshurun M, Perez G, Magen H, Henig I, Levi I, Shargian L, Trestman S, Rouvio U, Naparstek E, Ganon-Elazar E, Avivi I, Ram R (2017) Efficacy and safety of autologous hematopoietic cell transplantation in elderly patients with multiple myeloma: a retrospective national multisite cohort study. Ann Hematol 96(2):271\u2013278","journal-title":"Ann Hematol"},{"issue":"9594","key":"3528_CR10","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/S0140-6736(07)61537-2","volume":"370","author":"T Facon","year":"2007","unstructured":"Facon T, Mary JY, Hulin C, Benboubker L, Attal M, Pegourie B, Renaud M, Harousseau JL, Guillerm G, Chaleteix C, Dib M, Voillat L, Maisonneuve H, Troncy J, Dorvaux V, Monconduit M, Martin C, Casassus P, Jaubert J, Jardel H, Doyen C, Kolb B, Anglaret B, Grosbois B, Yakoub-Agha I, Mathiot C, Avet-Loiseau H (2007) Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomized trial. Lancet 370(9594):1209\u20131218","journal-title":"Lancet"},{"issue":"1","key":"3528_CR11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1182\/blood.V93.1.51","volume":"93","author":"DS Siegel","year":"1999","unstructured":"Siegel DS, Desikan KR, Mehta J, Singhal S, Fassas A, Munshi N, Anaissie E, Naucke S, Ayers D, Spoon D, Vesole D, Tricot G, Barlogie B (1999) Age is not a prognostic variable with autotransplants for multiple myeloma. Blood 93(1):51\u201354","journal-title":"Blood"},{"issue":"2","key":"3528_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/bmt.2014.255","volume":"50","author":"HW Auner","year":"2015","unstructured":"Auner HW et al (2015) Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years. Bone Marrow Transplant 50(2):209\u2013215","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"3528_CR13","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1016\/j.bbmt.2014.07.013","volume":"20","author":"M Sharma","year":"2014","unstructured":"Sharma M, Zhang MJ, Zhong X, Abidi MH, Akpek G, Bacher U, Callander NS, Dispenzieri A, Freytes CO, Fung HC, Gale RP, Gasparetto C, Gibson J, Holmberg LA, Kindwall-Keller TL, Klumpp TR, Krishnan AY, Landau HJ, Lazarus HM, Lonial S, Maiolino A, Marks DI, Mehta P, Mikhael JR, Nishihori T, Olsson R, Ramanathan M, Roy V, Savani BN, Schouten HC, Scott E, Tay J, To LB, Vesole DH, Vogl DT, Hari P (2014) Older patients with myeloma derive similar benefit from autologous transplantation. Biol Blood Marrow Transplant 20(11):1796\u20131803","journal-title":"Biol Blood Marrow Transplant"},{"key":"3528_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/394792","volume":"2014","author":"S Ozaki","year":"2014","unstructured":"Ozaki S, Shimizu K (2014) Autologous stem cell transplantation in elderly patients with multiple myeloma: past, present, and future. Biomed Res Int 2014:1\u20137. \n                    https:\/\/doi.org\/10.1155\/2014\/394792","journal-title":"Biomed Res Int"},{"key":"3528_CR15","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.bbmt.2017.03.012","volume":"23","author":"L Sanchez","year":"2017","unstructured":"Sanchez L, Sylvester M, Parrondo R, Mariotti V, Eloy JA, Chang VT (2017) In-hospital mortality and post-transplantation complications in elderly multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation: a population-based study. Biol Blood Marrow Transplant 23:1203\u20131207. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2017.03.012","journal-title":"Biol Blood Marrow Transplant"},{"key":"3528_CR16","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/sj.bmt.1701232","volume":"21","author":"C Dumontet","year":"1998","unstructured":"Dumontet C, Ketterer N, Espinouse D, Neidhardt EM, Moullet I, Thieblemont C, Salles G, Coiffier B (1998) Reduced progression-free survival in elderly patients receiving intensification with autologous peripheral blood stem cell reinfusion for multiple myeloma. Bone Marrow Transplant 21:1037\u20131041. \n                    https:\/\/doi.org\/10.1038\/sj.bmt.1701232","journal-title":"Bone Marrow Transplant"},{"key":"3528_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2016.04.004","volume":"62","author":"M Merz","year":"2016","unstructured":"Merz M, Jansen L, Castro FA, Hillengass J, Salwender H, Weisel K, Scheid C, Luttmann S, Emrich K, Holleczek B, Katalinic A, Nennecke A, Straka C, Langer C, Engelhardt M, Einsele H, Kr\u00f6ger N, Beelen D, Dreger P, Brenner H, Goldschmidt H, GEKID Cancer Survival Working Group and the DRST (2016) Survival of elderly patients with multiple myeloma-effect of upfront autologous stem cell transplantation. Eur J Cancer 62:1\u20138","journal-title":"Eur J Cancer"},{"key":"3528_CR18","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/sj.bmt.1705486","volume":"38","author":"HD Klepin","year":"2006","unstructured":"Klepin HD, Hurd D (2006) Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions? Bone Marrow Transplant 38:585\u2013592. \n                    https:\/\/doi.org\/10.1038\/sj.bmt.1705486","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"3528_CR19","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1016\/j.bbmt.2013.08.002","volume":"19","author":"LJ Costa","year":"2013","unstructured":"Costa LJ, Zhang MJ, Zhong X, Dispenzieri A, Lonial S, Krishnan A, Freytes C, Vesole D, Gale RP, Anderson K, Wirk B, Savani BN, Waller EK, Schouten H, Lazarus H, Meehan K, Sharma M, Kamble R, Vij R, Kumar S, Nishihori T, Kindwall-Keller T, Saber W, Hari PN (2013) Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myeloma. Biol Blood Marrow Transplant 19(11):1615\u20131624","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"3528_CR20","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/bmt.2015.106","volume":"50","author":"TM Wildes","year":"2015","unstructured":"Wildes TM, Finney JD, Fiala M, Gao F, Vij R, Stockerl-Goldstein K, Carson KR, Mikhael J, Colditz G (2015) High-dose therapy and autologous stem cell transplant in older adults with multiple myeloma. Bone Marrow Transplant 50(8):1075\u20131082","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"3528_CR21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000357394","volume":"132","author":"S Ozaki","year":"2014","unstructured":"Ozaki S, Harada T, Saitoh T, Shimazaki C, Itagaki M, Asaoku H, Kuroda Y, Chou T, Yoshiki Y, Suzuki K, Murakami H, Hayashi K, Mina R, Palumbo A, Shimizu K, Japanese Society of Myeloma; European Myeloma Network (2014) Survival of multiple myeloma patients aged 65-70 years in the era of novel agents and autologous stem cell transplantation. A multicenter retrospective collaborative study of the Japanese Society of Myeloma and the European Myeloma Network. Acta Haematol 132(2):211\u2013219","journal-title":"Acta Haematol"},{"issue":"5","key":"3528_CR22","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/leu.2013.313","volume":"28","author":"SK Kumar","year":"2014","unstructured":"Kumar SK, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Pandey S, Kapoor P, Dingli D, Hayman SR, Leung N, Lust J, McCurdy A, Russell SJ, Zeldenrust SR, Kyle RA, Rajkumar SV (2014) Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia 28(5):1122\u20131128","journal-title":"Leukemia"},{"key":"3528_CR23","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","volume":"23","author":"P Greipp","year":"2005","unstructured":"Greipp P et al (2005) International Staging System for multiple myeloma. J Clin Oncol 23:3412\u20133420. \n                    https:\/\/doi.org\/10.1200\/JCO.2005.04.242","journal-title":"J Clin Oncol"},{"issue":"3","key":"3528_CR24","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","volume":"36","author":"BG Durie","year":"1975","unstructured":"Durie BG, Salmon SE (1975) A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 36(3):842\u2013854","journal-title":"Cancer"},{"key":"3528_CR25","unstructured":"National Cancer Institute (2010) Common Terminology Criteria for Adverse Events (CTCAE). Version 4.0. Publication No. 09\u20135410"},{"issue":"8","key":"3528_CR26","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","volume":"17","author":"S Kumar","year":"2016","unstructured":"Kumar S, Paiva B, Anderson KC, Durie B, Landgren O, Moreau P, Munshi N, Lonial S, Blad\u00e9 J, Mateos MV, Dimopoulos M, Kastritis E, Boccadoro M, Orlowski R, Goldschmidt H, Spencer A, Hou J, Chng WJ, Usmani SZ, Zamagni E, Shimizu K, Jagannath S, Johnsen HE, Terpos E, Reiman A, Kyle RA, Sonneveld P, Richardson PG, McCarthy P, Ludwig H, Chen W, Cavo M, Harousseau JL, Lentzsch S, Hillengass J, Palumbo A, Orfao A, Rajkumar SV, Miguel JS, Avet-Loiseau H (2016) International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol 17(8):e328\u2013e346","journal-title":"Lancet Oncol"},{"key":"3528_CR27","volume-title":"IBM SPSS Statistics for Windows, Version 20.0","author":"IBM Corp. Released","year":"2011","unstructured":"IBM Corp. Released (2011) IBM SPSS Statistics for Windows, Version 20.0. IBM Corp, Armonk"},{"key":"3528_CR28","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"S Rajkumar","year":"2014","unstructured":"Rajkumar S et al (2014) International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 15:e538\u2013e548. \n                    https:\/\/doi.org\/10.1016\/S1470-2045(14)70442-5","journal-title":"Lancet Oncol"},{"issue":"4","key":"3528_CR29","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.mayocp.2013.01.019","volume":"88","author":"JR Mikhael","year":"2013","unstructured":"Mikhael JR, Dingli D, Roy V, Reeder CB, Buadi FK, Hayman SR, Dispenzieri A, Fonseca R, Sher T, Kyle RA, Lin Y, Russell SJ, Kumar S, Bergsagel PL, Zeldenrust SR, Leung N, Drake MT, Kapoor P, Ansell SM, Witzig TE, Lust JA, Dalton RJ, Gertz MA, Stewart AK, Rajkumar SV, Chanan-Khan A, Lacy MQ, Mayo Clinic (2013) Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013. Mayo Clin Proc 88(4):360\u2013376","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"3528_CR30","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/bmt.2016.174","volume":"51","author":"E Muchtar","year":"2016","unstructured":"Muchtar E, Dingli D, Kumar S, Buadi FK, Dispenzieri A, Hayman SR, Wolf RC, Gastineau DA, Chakraborty R, Hogan WJ, Leung N, Kapoor P, Lacy MQ, Rajkumar SV, Gertz MA (2016) Autologous stem cell transplant for multiple myeloma patients 70 years or older. Bone Marrow Transplant 51(11):1449\u20131455","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"3528_CR31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.5144\/1658-3876.2011.30","volume":"4","author":"J Cheikh El","year":"2011","unstructured":"El Cheikh J et al (2011) Age at transplantation and outcome after autologous stem cell transplantation in elderly patients with multiple myeloma. Hematol Oncol Stem Cell Ther 4(1):30\u201336","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"1","key":"3528_CR32","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3109\/10428194.2011.606942","volume":"53","author":"Q Bashir","year":"2012","unstructured":"Bashir Q, Shah N, Parmar S, Wei W, Rondon G, Weber DM, Wang M, Orlowski RZ, Thomas SK, Shah J, Qureshi SR, Dinh YT, Popat U, Anderlini P, Hosing C, Giralt S, Champlin RE, Qazilbash MH (2012) Feasibility of autologous hematopoietic stem cell transplant in patients aged \u226570 years with multiple myeloma. Leuk Lymphoma 53(1):118\u2013122","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"3528_CR33","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.3324\/haematol.2016.151860","volume":"101","author":"C Straka","year":"2016","unstructured":"Straka C, Liebisch P, Salwender H, Hennemann B, Metzner B, Knop S, Adler-Reichel S, Gerecke C, Wandt H, Bentz M, Bruemmendorf TH, Hentrich M, Pfreundschuh M, Wolf HH, Sezer O, Bargou R, Jung W, Tr\u00fcmper L, Hertenstein B, Heidemann E, Bernhard H, Lang N, Frickhofen N, Hebart H, Schmidmaier R, Sandermann A, Dechow T, Reichle A, Schnabel B, Sch\u00e4fer-Eckart K, Langer C, Gramatzki M, Hinke A, Emmerich B, Einsele H (2016) Autotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trial. Haematologica 101(11):1398\u20131406","journal-title":"Haematologica"},{"issue":"5","key":"3528_CR34","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/sj.bmt.1702188","volume":"25","author":"B Sirohi","year":"2000","unstructured":"Sirohi B, Powles R, Treleaven J, Mainwaring P, Kulkarni S, Pandha H, Bhagwati N, Horton C, Singhal S, Mehta J (2000) The role of autologous transplantation in patients with multiple myeloma aged 65 years and over. Bone Marrow Transplant 25(5):533\u2013539","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"3528_CR35","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/ajh.21191","volume":"83","author":"SK Kumar","year":"2008","unstructured":"Kumar SK, Dingli D, Lacy MQ, Dispenzieri A, Hayman SR, Buadi FK, Rajkumar SV, Litzow MR, Gertz MA (2008) Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: results from a matched pair analysis. Am J Hematol 83(8):614\u2013617","journal-title":"Am J Hematol"},{"issue":"11","key":"3528_CR36","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.3324\/haematol.2016.150334","volume":"101","author":"L Garderet","year":"2016","unstructured":"Garderet L, Beohou E, Caillot D, Stoppa AM, Touzeau C, Chretien ML, Karlin L, Moreau P, Fontan J, Blaise D, Polge E, Gueye MS, Ikhlef S, Marjanovic Z, Labopin M, Mohty M (2016) Upfront autologous stem cell transplantation for newly diagnosed elderly multiple myeloma patients: a prospective multicenter study. Haematologica 101(11):1390\u20131397","journal-title":"Haematologica"},{"issue":"10","key":"3528_CR37","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1182\/blood-2004-02-0408","volume":"104","author":"A Palumbo","year":"2004","unstructured":"Palumbo A et al (2004) Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial. Blood 104(10):3052\u20133057","journal-title":"Blood"},{"issue":"1","key":"3528_CR38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/sj.leu.2403196","volume":"18","author":"A Palumbo","year":"2004","unstructured":"Palumbo A, Bringhen S, Bertola A, Cavallo F, Falco P, Massaia M, Bruno B, Rus C, Barbui A, Caravita T, Musto P, Pescosta N, Rossini F, Vignetti M, Boccadoro M (2004) Multiple myeloma: comparison of two dose-intensive melphalan regimens (100 vs 200 mg\/m(2)). Leukemia 18(1):133\u2013138","journal-title":"Leukemia"},{"issue":"3","key":"3528_CR39","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1046\/j.1365-2141.2001.02976.x","volume":"114","author":"A Badros","year":"2001","unstructured":"Badros A, Barlogie B, Siegel E, Morris C, Desikan R, Zangari M, Fassas A, Anaissie E, Munshi N, Tricot G (2001) Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years. Br J Haematol 114(3):600\u2013607","journal-title":"Br J Haematol"},{"key":"3528_CR40","doi-asserted-by":"publisher","first-page":"S133","DOI":"10.1016\/j.bbmt.2016.12.250","volume":"23","author":"A Desai","year":"2017","unstructured":"Desai A, Beitinjaneh A, Ramdial J, Ali R, Lekakis L, Pereira D, Kimble E, Florou V, Bravo G, Goodman M, Byrnes JJ, Jimenez AM, Saneeymehri S, Komanduri KV (2017) Safety of high-dose melphalan (200\u2009Mg\/M2) as conditioning for autologous stem cell transplantation for myeloma in elderly patients. Biol Blood Marrow Transplant 23:S133\u2013S134. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2016.12.250","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3528-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3528-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3528-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,26]],"date-time":"2019-10-26T19:26:05Z","timestamp":1572117965000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3528-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,27]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["3528"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3528-x","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,27]]},"assertion":[{"value":"22 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study has been evaluated and approved by our ethics committee, the Ethics Committee for Health of Centro Hospitalar de S\u00e3o Jo\u00e3o\/Faculty of Medicine of Oporto University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}